NCT05179577View on ClinicalTrials.gov

A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

442

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2027

Study Completion Date

April 30, 2027

Conditions

Spasticity

Interventions

DRUG

Arbaclofen

Arbaclofen Extended Release Tablets

DRUG

Placebo

Placebo tablets

All Listed Sponsors

lead

RVL Pharmaceuticals, Inc.

INDUSTRY